Erudio Healtherudio.com
Drug
Tarlatamab trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying tarlatamab: DeLLphi-309. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 8 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| DeLLphi-309 NCT06745323 · Amgen | small cell lung cancer | Phase 2 | 206 | 39 | Standard | Oct 27, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| DeLLphi-305 NCT06211036 · Amgen DeepView → | first-line extensive-stage small-cell lung cancer | Phase 3 | Deep | View | |||
| DeLLphi-301 NCT05060016 · Amgen DeepView → | relapsed/refractory small cell lung cancer | Phase 2 | Deep | View | |||
| DeLLphi-304 NCT05740566 · Amgen DeepView → | relapsed small cell lung cancer | Phase 3 | Deep | View | |||
| DeLLphi-300 NCT03319940 · Amgen DeepView → | previously treated small cell lung cancer | Phase 1 | Deep | View | |||
| DeLLphi-312 NCT07005128 · Amgen DeepView → | first-line extensive-stage small-cell lung cancer | Phase 3 | Deep | View | |||
| DeLLphi-306 NCT06117774 · Amgen DeepView → | limited-stage small cell lung cancer | Phase 3 | Deep | View | |||
| DeLLpro-300 NCT04702737 · Amgen FocusedView → | de novo or treatment emergent neuroendocrine prostate cancer | Phase 1 | Focused | View | |||
| DeLLphi-303 NCT05361395 · Amgen FocusedView → | first-line extensive-stage small-cell lung cancer | Phase 1 | Focused | View | |||